BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10755790)

  • 1. Uterine leiomyosarcoma--a Singapore experience.
    Soh LT; Chew SH; Ang L
    Aust N Z J Obstet Gynaecol; 1999 May; 39(2):246-8. PubMed ID: 10755790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
    Dusenbery KE; Potish RA; Argenta PA; Judson PL
    Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
    Ricci S; Giuntoli RL; Eisenhauer E; Lopez MA; Krill L; Tanner EJ; Gehrig PA; Havrilesky LJ; Secord AA; Levinson K; Frasure H; Celano P; Fader AN
    Gynecol Oncol; 2013 Dec; 131(3):629-33. PubMed ID: 24016408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of treatment failures in patients with early-stage uterine leiomyosarcoma.
    Gadducci A; Fabrini MG; Bonuccelli A; Moda S; Fanucchi A; Laddaga M; Facchini V
    Anticancer Res; 1995; 15(2):485-8. PubMed ID: 7763027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study.
    Li Y; Ren H; Wang J
    BMC Cancer; 2019 Jul; 19(1):697. PubMed ID: 31307426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.
    Mahdavi A; Monk BJ; Ragazzo J; Hunter MI; Lentz SE; Vasilev SA; Tewari KS
    Int J Gynecol Cancer; 2009 Aug; 19(6):1080-4. PubMed ID: 19820372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.
    Mancari R; Signorelli M; Gadducci A; Carinelli S; De Ponti E; Sesana S; Corso S; Chiappa V; Colombo N; Lissoni AA
    Gynecol Oncol; 2014 Jun; 133(3):531-6. PubMed ID: 24631454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in early uterine sarcoma.
    Hannigan EV; Freedman RS; Rutledge FN
    Gynecol Oncol; 1983 Feb; 15(1):56-64. PubMed ID: 6401640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant management of operated uterine sarcomas: A single institution experience.
    Cordoba A; Prades J; Basson L; Robin YM; Taïeb S; Narducci F; Hudry D; Bresson L; Chevalier A; Le Tinier F; Mirabel X; Lartigau É; Penel N; Leblanc É
    Cancer Radiother; 2019 Sep; 23(5):401-407. PubMed ID: 31351809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
    Dusenbery KE; Potish RA; Judson P
    Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas.
    Sorbe B
    Gynecol Oncol; 1985 Mar; 20(3):281-9. PubMed ID: 3838290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine leiomyosarcoma: analysis of treatment failures and survival.
    Gadducci A; Landoni F; Sartori E; Zola P; Maggino T; Lissoni A; Bazzurini L; Arisio R; Romagnolo C; Cristofani R
    Gynecol Oncol; 1996 Jul; 62(1):25-32. PubMed ID: 8690287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis.
    Bogani G; Fucà G; Maltese G; Ditto A; Martinelli F; Signorelli M; Chiappa V; Scaffa C; Sabatucci I; Lecce F; Raspagliesi F; Lorusso D
    Gynecol Oncol; 2016 Nov; 143(2):443-447. PubMed ID: 27481579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital.
    Dinh TA; Oliva EA; Fuller AF; Lee H; Goodman A
    Gynecol Oncol; 2004 Feb; 92(2):648-52. PubMed ID: 14766261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
    Sorbe B; Johansson B
    Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
    Gadducci A; Romanini A
    Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of radiotherapy treatment of uterine sarcoma.
    Sampath S; Gaffney DK
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):761-72. PubMed ID: 21783424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer®-accredited facilities.
    Vaz J; Tian C; Richardson MT; Chan JK; Mysona D; Rao UN; Powell MA; Shriver CD; Hamilton CA; Casablanca Y; Maxwell GL; Darcy KM
    Gynecol Oncol; 2020 Apr; 157(1):121-130. PubMed ID: 31954536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leiomyosarcoma of the uterus. A clinicopathologic study.
    Silverberg SG
    Obstet Gynecol; 1971 Oct; 38(4):613-28. PubMed ID: 5098491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.